1. Home
  2. UTMD vs MOLN Comparison

UTMD vs MOLN Comparison

Compare UTMD & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTMD
  • MOLN
  • Stock Information
  • Founded
  • UTMD 1978
  • MOLN 2004
  • Country
  • UTMD United States
  • MOLN Switzerland
  • Employees
  • UTMD N/A
  • MOLN N/A
  • Industry
  • UTMD Medical/Dental Instruments
  • MOLN
  • Sector
  • UTMD Health Care
  • MOLN
  • Exchange
  • UTMD Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • UTMD 219.4M
  • MOLN 218.1M
  • IPO Year
  • UTMD N/A
  • MOLN 2021
  • Fundamental
  • Price
  • UTMD $64.57
  • MOLN $5.42
  • Analyst Decision
  • UTMD
  • MOLN Hold
  • Analyst Count
  • UTMD 0
  • MOLN 1
  • Target Price
  • UTMD N/A
  • MOLN $4.50
  • AVG Volume (30 Days)
  • UTMD 26.5K
  • MOLN 17.4K
  • Earning Date
  • UTMD 10-29-2024
  • MOLN 08-26-2024
  • Dividend Yield
  • UTMD 1.87%
  • MOLN N/A
  • EPS Growth
  • UTMD N/A
  • MOLN N/A
  • EPS
  • UTMD 4.28
  • MOLN N/A
  • Revenue
  • UTMD $44,078,000.00
  • MOLN $7,105,397.00
  • Revenue This Year
  • UTMD N/A
  • MOLN N/A
  • Revenue Next Year
  • UTMD N/A
  • MOLN $29.41
  • P/E Ratio
  • UTMD $14.99
  • MOLN N/A
  • Revenue Growth
  • UTMD N/A
  • MOLN N/A
  • 52 Week Low
  • UTMD $63.38
  • MOLN $3.32
  • 52 Week High
  • UTMD $87.21
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • UTMD 42.23
  • MOLN 47.39
  • Support Level
  • UTMD $63.65
  • MOLN $5.11
  • Resistance Level
  • UTMD $67.60
  • MOLN $6.15
  • Average True Range (ATR)
  • UTMD 1.33
  • MOLN 0.39
  • MACD
  • UTMD -0.21
  • MOLN -0.09
  • Stochastic Oscillator
  • UTMD 17.23
  • MOLN 27.43

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: